Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Pharmaceuticals
100.0
%
| 27 | 100.0 % | 29 | 100.0 % | +6.12% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
60.0
%
| 16 | 60.0 % | 17 | 60.0 % | +6.12% |
United States
40.0
%
| 11 | 40.0 % | 11 | 40.0 % | +6.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15/22/15 |
James Bowen
IRC | Investor Relations Contact | - | - |
Emilio Presti
SAM | Sales & Marketing | - | - |
Diane Gajewczyk
PRN | Corporate Officer/Principal | - | 05/18/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 08/16/08 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 21/23/21 |
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
Hubert Walinski
BRD | Director/Board Member | - | 21/23/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,107,316 | 13,376,443 ( 55.49 %) | 0 | 55.49 % |
Company contact information
Cipher Pharmaceuticals, Inc.
5750 Explorer Drive Suite 404
L4W 0A9, Mississauga
+905-602-5840
http://www.cipherpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 32TCr | |
+0.24% | 27TCr | |
+13.09% | 24TCr | |
+7.00% | 20TCr | |
-6.50% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr |